PDC*line Pharma is one of the three nominees for the 2020 BVA Award Venture company of the year!
We are very pleased to announce that PDC*line Pharma is one of the three nominees for the 2020 BVA Award Venture company of the year!
THE BELGIAN VENTURE CAPITAL & PRIVATE EQUITY ASSOCIATION AWARD
The Belgian Venture Capital & Private Equity Association (in short “BVA”) is the professional association representing the venture capital and private equity community in Belgium. BVA members are investment fund managers and professionals who deliver services to the community.
The BVA Private Equity and Venture Capital award aim is to reward and celebrate high-performing Belgian companies that are backed by a private equity or venture capital investor, thus highlighting private equity as an asset class supporting the development and growth of Belgian businesses.
Venture company of the year, defined as a company backed by a venture capital firm, where the investment was primarily aimed at developing an innovative product or service, at scaling-up the company or accelerating the go-to-market process;
Growth company of the year, defined as a company backed by a private equity firm, typically through a minority investment, that is looking to expand and improve operations or enter new markets in order to accelerate its growth;
Buy-out company of the year, defined as a company backed by a private equity firm holding a majority or a controlling stake, and financed through a mix of equity and debt.
NOMINATION AND SELECTION PROCESS
A long-list of companies, nominated by the BVA members and selected industry observers, is compiled by the BVA (April-May);
The jury selects three nominees in each award category (June);
Each nominee completes a concise company presentation template (July-August) and the CEO gives an in person presentation to the jury, who elects the winner in each category (September);
The name of the winners are disclosed at the occasion of BVA Awards Ceremony & Cocktail (October).